Recently, when I walked into the disposable medical supplies production workshop of Nanchang Ruiao Jucheng Biotechnology Co., Ltd. located in Nanchang Economic and Technological Development Zone, Jiangxi Province, I saw the workers on the intelligent production line skillfully carrying out product inspection, assembly, packaging and other tasks, and the scene was full of bustling production.

It is understood that Nanchang Ruiao Jucheng Biotechnology Co., Ltd. is a high-tech enterprise specializing in biotechnology research, development and production . "At present, the company's production orders have been scheduled until November, and the products are in short supply. In order to meet the production needs of orders, we have carried out targeted expansion by adding new production lines." Zhou Bin, chairman of Nanchang Ruiao Jucheng Biotechnology Co., Ltd., introduced.

At present, the company has built instrument production workshops and reagent production workshops, which can produce 100 flow cytometers and 5 million diagnostic kits annually; it has formed a research and development team mainly focusing on instruments, flow analysis, and molecular diagnosis, and is expected to register 500 Class II medical device certificates and file 200 Class I medical device certificates.

In the production workshop of Jiangxi Kanglite Xinsen Pharmaceutical Raw Materials Co., Ltd. located in Xinjian District, Nanchang City, workers are busy completing the production and processing of coix seed oil (for injection) products through processes such as feeding, extraction, refining, and filling.

It is understood that the company produces modern Chinese medicine coix seed oil (for injection) and other natural extracts through the industrialization technology of supercritical carbon dioxide extraction of effective ingredients of traditional Chinese medicine, which are mainly used for the research and development and production of anti- tumor Chinese medicine series products.

"Compared with traditional extraction processes, our company's supercritical extraction process uses low-temperature extraction and separation technology, which makes the product unaffected by high temperatures, has higher purity, and has no organic solvent residue, further improving the product's market competitiveness." Zhou Yan, head of administrative human resources at Jiangxi Kanglaite Xinsen Pharmaceutical Co., Ltd., introduced that in order to meet market demand, the company added a supercritical extraction production line this year, which greatly enhanced the company's production capacity.

"At present, we are pushing the production 'progress bar' to its fullest, and the supercritical extraction production line is running 24 hours a day. We expect to produce nearly 200 tons of coix seed oil this year, with revenue exceeding 470 million yuan," said Zhou Yan.

It is understood that in recent years, the development of Nanchang's bio-pharmaceutical industry has "blossomed in many places", forming the Jiangzhong Medicine Valley core area of China (Nanchang) Traditional Chinese Medicine Science and Technology Innovation City and Jinxian County Modern Medical Equipment Science and Technology Innovation City, and the Nanchang High-tech Zone, Nanchang County (Xiaolan Economic Development Zone), and Nanchang Economic Development Zone each have their own focus on the "two-city innovation-led, three-zone efficient coordination" industrial development pattern, and the overall development trend is stable and improving.

https://news.pharmnet.com.cn/news/2024/05/23/592088.html